Quoin Pharmaceuticals (QNRX) to Release Quarterly Earnings on Thursday

Quoin Pharmaceuticals (NASDAQ:QNRX) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Thursday, August 7th. Analysts expect the company to announce earnings of ($6.83) per share for the quarter.

Quoin Pharmaceuticals (NASDAQ:QNRX) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($6.50) EPS for the quarter, missing the consensus estimate of ($3.85) by ($2.65). On average, analysts expect Quoin Pharmaceuticals to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Quoin Pharmaceuticals Trading Down 0.6%

Quoin Pharmaceuticals stock opened at $6.66 on Friday. Quoin Pharmaceuticals has a 12 month low of $5.01 and a 12 month high of $54.95. The business’s 50 day simple moving average is $8.69 and its 200 day simple moving average is $9.37. The company has a market cap of $3.93 million, a price-to-earnings ratio of -0.14 and a beta of 1.44.

About Quoin Pharmaceuticals

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.